Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

  • Wednesday, June 24, 2026

Publisher Publisher - emeastartups

  • Home
  • STARTUPS
  • DEALS
  • GUIDES
  • ANALYSIS
  • CALENDAR
emeastartups
  • Home
  • new drug
Browsing Tag

new drug

NEWS

Omicron variant leads to safer investments

Dec 23, 2021
The Omicron variant poses a dilemma for the global economy, deterring investors from risky decisions and investments. It is known…
Newsletter

Get the best of Business News delivered to your inbox daily

Recent Posts

admin
View all posts
ADMIN
View all posts
Newsroom
View all posts
manouselis
View all posts

Editors' Picks

PhysicsX Secures $300 Million to Transform Engineering with…

hephaistos.bio raises €161,000 to transform chemical…

Quartermaster: Raises $43 Million to Create a…

LawX: The Legaltech Startup Secures €7.5 Million to Create…

Former Anduril Engineer Raises $42 Million to Create the…

most viewed

DEALS

Real Consulting acquires 60% of Cloudideas, a german Salesforce service provider

MWC15

D-Link Enters Smart Home Industry, while Users Embrace the Inter-Connected Era

NEWS

Cribl raised 150 million dollars to enhance remote work

around the world

NEWS

ICON: 207 million dollars for the construction of 3D-printed houses

STARTUPS

These are the first 50 Startups to qualify for the next phase of LG’s Incubation Program

STARTUPS

Capital $25M for Rapid Micro Biosystems

  • Home
  • STARTUPS
  • DEALS
  • GUIDES
  • ANALYSIS
  • CALENDAR
© 2026 - emeastartups. All Rights Reserved.
Website crafted with ♥ by: OFB
emeastartups
Manage your privacy

To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Statistics

Marketing

Features
Always active

Always active
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Manage options
  • {title}
  • {title}
  • {title}
Sign in
  • Home
  • STARTUPS
  • DEALS
  • GUIDES
  • ANALYSIS
  • CALENDAR

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.